Molecular profiling, also known as tumor profiling or cancer profiling, is genetic testing of cancer DNA to identify the specific genetic makeup of the cancer. All cells are made up of genes, which contain genetic codes. Every cancer cell has its own genetic code or profile. The molecular profile of the cancer reveals characteristics about the cancer cells, mutational profiles and specific genes in the cancer cells that may provide insight or information on treatment plans. Our genetic counselors provide eligible cancer patients and their oncologists with information about the biology of their cancer through molecular profiling.
Molecular profiling enables cutting edge precision medicine for cancer treatments. Profiling tumors and hematologic (blood) cancers can assist patients in receiving the most precise cancer therapies and treatment plans. The goal with precision medicine like cancer profiling is to reduce unnecessary treatments with additional side-effects and to create better outcomes. Knowing the genetic profile of the cancer, along with additional information about a patient’s cancer and medical history, oncology health care teams can create personalized treatment plans for individual cancers.
For blood cancers there are no tumors to profile but there is molecular cancer profiling of hematologic (blood) cancers. Hematologic cancers make up 9.5% of new cancers cases per year being diagnosed in the U.S. Just as with tumors, there are opportunities to target mutations in blood cancers, allowing accurate characterization for personalized treatment opportunities.
Genetic profiling of hematologic and solid tumor cancers is common for a long list of specific cancer types. There is an evolving range of known cancer genes and detection rates by cancer type. These cancers include but are not limited to: lung, colon, breast, melanoma, gastric, ovarian, bladder, prostate, colorectal, lymphoma, endometrial, esophageal, cervical, cholangio, pancreatic, glioblastoma, head and neck, liver, kidney, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, Lymphomas, Multiple Myeloma, Sarcomas, and Adenoid cystic carcinoma (ACC).
At MyOncoPath our team of board certified genetic counselors are here to recommend, educate and guide health care providers and patients in understanding their tumor or blood cancer profiling options. If interested in a detailed scientific understanding of the types of tumor profiling please click here to view My Cancer Genome’s Types of Molecular Tumor Testing webpage. Knowledge of the tumor profile helps patients and providers select treatment options, including clinical trials that are likely to work best and may have not been considered otherwise. For example our counselors help identify and coordinate the tumor gene sequencing required to enroll in clinical trials. Contact us for more details about molecular profiling options available now – call 1.888.335.8006 or 1.925.266.5777 or email firstname.lastname@example.org.